![]() |
Benign Essential Blepharospasm Research Foundation (BEBRF) |
| Home | Blepharospasm | Related disorders | Treatments | Patient support | The BEBRF | FAQ | Blepharospasm Research |
Site Search |
|
Information in other languages
What's new Contact us Help fund BEBRF BEBRF on-line store On-line resources Medical Information Dystonia advocacy Blepharospasm Bulletin Board |
Medical Reports to Support Your SSD CasePerhaps the most important part of your application for Social Security Disability is getting clear, understandable letters from your doctors about blepharospasm and how it affects you. Sometimes the Social Security people may require you to be evaluated by a doctor who is totally unacquainted with the malady. In any case it is wise for the patient to supply the doctor with as much supporting material as possible. The Foundation includes in the packet a sample of several reprinted medical articles to aid the doctor in writing the letter. A collection of reports and papers follows. Spanning the past five years, all appeared in the BEBRF Newsletter. The reader should be aware that changes and advancements do occur in medical technology. These articles are included because they have contributed over the years to the body of knowledge about Blepharospasm and related disorders. Essential Blepharospasm, Neil R. Miller, M.D., Professor of Neuro-Ophthalmology, Johns Hopkins-Wilmer Eye Institute, Baltimore, Maryland. Secondary Blepharospasm, Joseph Jankovic, M.D., Professor of Neurology and Director of Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas. Blepharospasm and Tardive Dyskinesia, Mark Hallett, M.D., Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. Blepharospasm: Neurologic Considerations, Joseph Jankovic, M.D., Professor of Neurology and Director of Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas. Botulinum Toxin for Human Treatment, Edward J. Schantz, M.D. Acute and Chronic Effects of Botulinum Toxin in the Management of Blepharospasm, Jonathan J. Dutton, M.D., Ph.D., The Duke University Eye Center, Durham, North Carolina. The Limited Myectomy in the Management of Essential Blepharospasm, Jonathan J. Dutton, M.D., Ph.D., The Duke University Eye Center, Durham, North Carolina. Update on the Limited Myectomy, James R. Patrinely, M.D., F.A.C.S., Clinical Associate Professor of Ophthalmology and Plastic Surgery, Baylor College of Medicine, Houston, Texas and Plastic Eye Surgery Associates, PA, Pensacola, Florida. Updated Myectomy Procedure, Richard L. Anderson, M.D., Professor of Ophthalmology, Chief - Division Ophthalmic Plastic, and Reconstructive Surgery, University of Utah, Salt Lake City, Utah. Meige's Syndrome, George W. Paulson, M.D., Kurtz Professor of Neurology, The Ohio State University Medical Center, Columbus, Ohio. Home > Patient Support > Disability index > Top of this page |
| Disclaimer | Site map | Webmaster | Dedication | Updated: 2006 |